Terafab — $16.8B Phase 1 · Q3 2028 chip volume target · 'Most valuable building in the world' · Global GPU shortage → self-build only option
Published · Updated · By Investus editorial desk (SUNRYU Partners)
On Tesla's Q3 2026 earnings call, Musk called Terafab 'the most valuable building in the world, with economic value placing it in the top 20 of countries.' Phase 1 investment: $16.8B. Timeline: machinery commissioning H1 2027; first test chip May–June 2027; chip volume production Q3 2028. NVIDIA GB300/H100, Google TPU, Amazon Trainium — all out of stock globally. Self-build is the only option. 10+ Korean semiconductor firms under NDA.
What Happened
Elon Musk said on Tesla's Q3 2026 earnings call: 'The Terafab, I think, will be the most valuable building in the world, and will probably have an economic value that will place it in the top 20 of countries.' Phase 1 investment: $16.8B. Timeline: machinery commissioning starts H1 2027; first test chip around May–June 2027 ('just to see if we can make any chip at all'); chip volume production target Q3 2028. Korean semiconductor firms: 10+ under NDA.
On the SPCX Q3 earnings call, Musk confirmed that SpaceX attempted to procure external GPU resources and failed across the board. NVIDIA GB300, GB200, legacy H100, Google TPU, and Amazon Trainium — all were out of stock. With SuperIntelligence AI revenue growing +830% YoY in Q3, compute demand exploded, making self-build the only viable path. SpaceX is currently scaling its Brownsville GPU cluster and Memphis data center directly.
Terafab is being built at Grimes County, Texas — approximately 100 million square feet (~9.3M m²). It is the largest single semiconductor manufacturing complex ever planned, built by an entirely new entrant. Upon completion, it closes the loop on vertical integration for Tesla and SpaceX AI chip supply.
More Context
GPU shortage is not a SpaceX-specific problem. NVIDIA, Google, and Amazon supply chains are pre-committed across the board. Companies with sudden AI demand surges — like SPCX — structurally cannot source externally. Vertical integration via custom AI chip fab is becoming a survival requirement for large-scale AI companies. Terafab solves this permanently.
NDAs with 10+ Korean semiconductor firms span the full supply chain: memory, packaging, materials, and equipment. The $16.8B Phase 1 covers construction and machinery commissioning; additional investment follows to reach volume production. With earnings-call-level public disclosure, the Q3 2028 timeline is a public commitment.
Key View
Deutsche Bank: Terafab completion is a potential game-changer for AI semiconductor supply — GPU cost structure for SpaceX and Tesla restructures fundamentally upon 2028 volume production success. JPMorgan: self-sourcing compute post-Terafab is the structural margin driver for SPCX's AI segment. The $16.8B Phase 1 is the seed capital for what becomes a multi-hundred-billion-dollar self-supplied chip ecosystem.
Sources & further reading
See the body and ticker IR links for sources on this note.
Related Guides
Related articles
Anthropic's $120.5B SpaceX Compute Deal: What the 90-Day Exit Clause Means After the 'Mid-2027' Report
Anthropic's S-1/A caps SpaceX compute at $120.5B with a 90-day exit after early 2027. What the 'mid-2027' report adds and what remains unconfirmed.
35,578 Open Grok Build Apps: What Claroc Measured and What SpaceXSI Disputes
SpaceXSI's Grok Build: Claroc says 35,578 published apps opened with no sign-in. What was measured, what SpaceXSI disputes, and open questions.
Starship Flight 15 Explained: SpaceX's First Attempt to Catch Both Stages, What Is Confirmed and What Investors Should Watch
SpaceX says Starship Flight 15 is preparing to launch as soon as Friday, November 13, 2026, pending regulatory approval, on the first plan to catch both Super Heavy and the Starship upper stage. The 75-minute window opens at 4:45 p.m. CT. This note separates confirmed facts, company plans, secondary reports, and open questions. It is not a buy, a sell, or a share-price call.
Disclaimer
This article is editorial research for informational purposes only. It is not investment advice, a recommendation, or a solicitation to buy or sell any security, and does not guarantee any return. Markets carry risk of loss. Verify figures against the primary sources before making decisions.